INCYTE CORP·4

Jan 29, 4:27 PM ET

Friedman Steven M. 4

4 · INCYTE CORP · Filed Jan 29, 2009

Insider Transaction Report

Form 4
Period: 2009-01-27
Friedman Steven M.
EVP, Biology & Preclinical Dev
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2009-01-27+13,90413,904 total
    Exercise: $3.11Exp: 2016-01-26Common Stock (13,904 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2009-01-27+61,09661,096 total
    Exercise: $3.11Exp: 2016-01-26Common Stock (61,096 underlying)
Footnotes (1)
  • [F1]Option begins vesting on grant date in 25 installments, the first 33.33% vesting on the one year anniversary of the grant date and the remaining 66.67% vesting in equal monthly installments during the two year period thereafter. Vesting may be accelerated and exercise term may be extended upon occurence of certain events.

Documents

1 file
  • 4
    rrd231326.xmlPrimary